Research Article
Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population Seroprevalence
Table 2
VZV, EBV, and CMV seroprevalence.
| | VZV () | EBV () | CMV () | |
| Seroprevalence | 97.6% () | 86.5% () | 30% () | | <60 years | 98% () | 84% () | 25.75% () | ā | >60 years | 94% () | 100% () | 50% () | ā |
|
|